EP Biocomposites Balance Sheet Health
Financial Health criteria checks 4/6
EP Biocomposites has a total shareholder equity of ₹86.4M and total debt of ₹11.6M, which brings its debt-to-equity ratio to 13.5%. Its total assets and total liabilities are ₹112.9M and ₹26.5M respectively. EP Biocomposites's EBIT is ₹7.6M making its interest coverage ratio 41.3. It has cash and short-term investments of ₹18.4M.
Key information
13.5%
Debt to equity ratio
₹11.65m
Debt
Interest coverage ratio | 41.3x |
Cash | ₹18.36m |
Equity | ₹86.35m |
Total liabilities | ₹26.51m |
Total assets | ₹112.87m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 543595's short term assets (₹88.9M) exceed its short term liabilities (₹15.0M).
Long Term Liabilities: 543595's short term assets (₹88.9M) exceed its long term liabilities (₹11.5M).
Debt to Equity History and Analysis
Debt Level: 543595 has more cash than its total debt.
Reducing Debt: Insufficient data to determine if 543595's debt to equity ratio has reduced over the past 5 years.
Debt Coverage: 543595's debt is not well covered by operating cash flow (19.3%).
Interest Coverage: 543595's interest payments on its debt are well covered by EBIT (41.3x coverage).